ANEB

Anebulo Pharmaceuticals
ANEB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$48.48M
EV
$33.48M
Shares Outstanding
41.08M
Beta
-1.14

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$8.00
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Anebulo Pharmaceuticals, Inc.

gainify
ANEB

Anebulo Pharmaceuticals, Inc.

ANEB

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the ...

Sector

Healthcare

Industry

Biotechnology

CEO

Cunningham, Richard

Employees

3

IPO Date

2021-05-07

Headquarters

1017 Ranch Road 620 South, Suite 107, Lakeway, Texas, 78734, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved